This toolkit from the Bloomberg School of Public Health at Johns Hopkins University provides guidance on using data to understand the nature and the scope of the opioid crisis and how to use data to help design population level responses to the opioid epidemic. Includes information from a population estimation study in rural West Virginia.
An analysis data by Centers for Disease Control and Prevention staff that shows that the incidence of multiple naloxone administrations by first responders increased significantly from 2012 to 2015 and varied by region of the country. Funding Source: Centers for Disease Control and Prevention
The prescription monitoring program in Washington state sends prescribers a feedback report if one of 4 prescribing measures lies at or above the 95th percentile of all prescribers:. This is a sample feedback report. Funding Source: Washington State Department of Health
The Tennessee Department of Health developed an integrated data collection and analysis program on opioid related issues and published this comprehensive report in 2019. The report includes epidemiologic data on risk measures and trends to understand the opioid crisis in Tennessee and summarizes ongoing data efforts and data collaborations in the state. Funding Source: Tennessee Department of Health
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from West Virginia’s PDMP
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from Washington’s PDMP
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Virginia’s PDMP.
This 2018 report from the Prescription Drug Monitoring Program (PDMP) Training and Technical Assistance Center at Brandeis University describes the history of PDMPs in the United States. From the first program established in 1918 in New York through Supreme Court decisions until the 21st century when 49 states, the
This 2019 journal article compares dentist opioid prescribing rates in the United States and England. While dental service rates are generally similar between the countries, US dentists prescribed opioids 37 times more than English dentists, they prescribed a greater range of opioid medications, and also prescribed long acting opioids which English dentists did not.
This 2019 report from the Prescription Drug Monitoring Program (PDMP) Training and Technical Assistance Center provides guidance to PDMP administrators on how to create standard procedures to share de-identified PDMP data with researchers for public health surveillance, research,